Concepts (279)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stress Disorders, Post-Traumatic | 49 | 2023 | 568 | 8.220 |
Why?
|
| Sleep | 23 | 2025 | 185 | 5.510 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 12 | 2022 | 70 | 4.510 |
Why?
|
| Sleep, REM | 9 | 2017 | 11 | 1.830 |
Why?
|
| Autonomic Nervous System | 5 | 2019 | 39 | 1.750 |
Why?
|
| Fear | 7 | 2022 | 272 | 1.520 |
Why?
|
| Polysomnography | 13 | 2019 | 43 | 1.410 |
Why?
|
| Urban Population | 6 | 2016 | 374 | 1.390 |
Why?
|
| Heart Rate | 6 | 2019 | 266 | 1.210 |
Why?
|
| Veterans | 6 | 2018 | 210 | 1.190 |
Why?
|
| Young Adult | 23 | 2025 | 5080 | 1.180 |
Why?
|
| Wounds and Injuries | 6 | 2015 | 193 | 1.110 |
Why?
|
| Circadian Rhythm | 4 | 2016 | 236 | 1.090 |
Why?
|
| Humans | 77 | 2026 | 43102 | 1.040 |
Why?
|
| Adult | 45 | 2025 | 13872 | 0.970 |
Why?
|
| Male | 51 | 2025 | 23409 | 0.850 |
Why?
|
| Adolescent | 22 | 2025 | 6081 | 0.840 |
Why?
|
| Resilience, Psychological | 2 | 2016 | 106 | 0.830 |
Why?
|
| Female | 49 | 2025 | 24698 | 0.820 |
Why?
|
| Stress, Psychological | 5 | 2018 | 661 | 0.800 |
Why?
|
| Blood Pressure | 3 | 2025 | 666 | 0.770 |
Why?
|
| Polymorphism, Genetic | 2 | 2016 | 201 | 0.730 |
Why?
|
| Anxiety Disorders | 5 | 2023 | 322 | 0.680 |
Why?
|
| Psychiatric Status Rating Scales | 6 | 2018 | 282 | 0.670 |
Why?
|
| Antipsychotic Agents | 5 | 2008 | 80 | 0.610 |
Why?
|
| Autonomic Nervous System Diseases | 2 | 2016 | 12 | 0.610 |
Why?
|
| Sleep Paralysis | 2 | 2008 | 2 | 0.570 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 140 | 0.570 |
Why?
|
| Arousal | 2 | 2019 | 95 | 0.570 |
Why?
|
| Perception | 1 | 2019 | 215 | 0.530 |
Why?
|
| Military Personnel | 1 | 2018 | 110 | 0.530 |
Why?
|
| Residence Characteristics | 2 | 2018 | 363 | 0.530 |
Why?
|
| Darkness | 1 | 2017 | 28 | 0.520 |
Why?
|
| Minority Groups | 3 | 2026 | 690 | 0.520 |
Why?
|
| Time Factors | 7 | 2025 | 1857 | 0.510 |
Why?
|
| Hydrocortisone | 2 | 2014 | 93 | 0.500 |
Why?
|
| Period Circadian Proteins | 1 | 2016 | 37 | 0.500 |
Why?
|
| Sleep Stages | 1 | 2016 | 7 | 0.490 |
Why?
|
| Emotions | 1 | 2019 | 254 | 0.480 |
Why?
|
| Receptors, Odorant | 1 | 2016 | 44 | 0.480 |
Why?
|
| Actigraphy | 3 | 2025 | 17 | 0.470 |
Why?
|
| Severity of Illness Index | 9 | 2016 | 719 | 0.470 |
Why?
|
| Risperidone | 2 | 2006 | 5 | 0.460 |
Why?
|
| Combat Disorders | 2 | 2006 | 12 | 0.460 |
Why?
|
| Obesity | 2 | 2014 | 1151 | 0.460 |
Why?
|
| Research Design | 4 | 2013 | 385 | 0.450 |
Why?
|
| Theta Rhythm | 1 | 2014 | 11 | 0.420 |
Why?
|
| Hypnotics and Sedatives | 2 | 2005 | 27 | 0.420 |
Why?
|
| Risk Factors | 11 | 2016 | 3994 | 0.410 |
Why?
|
| Academies and Institutes | 1 | 2013 | 39 | 0.400 |
Why?
|
| Survivors | 2 | 2012 | 152 | 0.400 |
Why?
|
| Electrocardiography | 4 | 2018 | 185 | 0.390 |
Why?
|
| Life Change Events | 6 | 2012 | 109 | 0.390 |
Why?
|
| Middle Aged | 25 | 2024 | 12222 | 0.390 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2013 | 48 | 0.390 |
Why?
|
| Minority Health | 1 | 2013 | 95 | 0.390 |
Why?
|
| Cytokines | 1 | 2017 | 678 | 0.390 |
Why?
|
| Comorbidity | 8 | 2014 | 737 | 0.380 |
Why?
|
| DNA Methylation | 1 | 2016 | 403 | 0.380 |
Why?
|
| Cooperative Behavior | 2 | 2013 | 269 | 0.370 |
Why?
|
| Amygdala | 1 | 2013 | 125 | 0.370 |
Why?
|
| Cognition Disorders | 1 | 2014 | 243 | 0.370 |
Why?
|
| Weight Loss | 1 | 2013 | 137 | 0.360 |
Why?
|
| Community-Institutional Relations | 1 | 2013 | 219 | 0.350 |
Why?
|
| Depressive Disorder | 3 | 2008 | 187 | 0.330 |
Why?
|
| Fatigue | 1 | 2011 | 100 | 0.330 |
Why?
|
| Wakefulness | 4 | 2018 | 24 | 0.310 |
Why?
|
| Sleep Deprivation | 2 | 2008 | 28 | 0.310 |
Why?
|
| Universities | 1 | 2013 | 559 | 0.310 |
Why?
|
| Mental Health | 2 | 2024 | 385 | 0.310 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2009 | 15 | 0.290 |
Why?
|
| Bipolar Disorder | 2 | 2007 | 84 | 0.290 |
Why?
|
| Receptors, Serotonin | 1 | 2009 | 23 | 0.290 |
Why?
|
| Healthcare Disparities | 2 | 2013 | 590 | 0.290 |
Why?
|
| Mental Recall | 1 | 2009 | 84 | 0.290 |
Why?
|
| Conditioning, Classical | 1 | 2009 | 67 | 0.280 |
Why?
|
| Body Mass Index | 2 | 2025 | 925 | 0.270 |
Why?
|
| Alleles | 1 | 2009 | 352 | 0.270 |
Why?
|
| Extinction, Psychological | 1 | 2009 | 104 | 0.270 |
Why?
|
| Prevalence | 6 | 2015 | 1612 | 0.260 |
Why?
|
| Health Status Disparities | 1 | 2013 | 719 | 0.250 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 3156 | 0.250 |
Why?
|
| Sympathetic Nervous System | 3 | 2017 | 57 | 0.250 |
Why?
|
| Specialties, Surgical | 1 | 2026 | 7 | 0.250 |
Why?
|
| Dyssomnias | 1 | 2006 | 2 | 0.240 |
Why?
|
| Trauma Severity Indices | 2 | 2016 | 31 | 0.240 |
Why?
|
| District of Columbia | 3 | 2014 | 80 | 0.240 |
Why?
|
| Double-Blind Method | 4 | 2022 | 317 | 0.230 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2005 | 2 | 0.230 |
Why?
|
| Triazoles | 2 | 2022 | 102 | 0.220 |
Why?
|
| Mentors | 1 | 2026 | 145 | 0.220 |
Why?
|
| Internship and Residency | 1 | 2026 | 146 | 0.210 |
Why?
|
| Alcoholism | 2 | 2008 | 305 | 0.210 |
Why?
|
| Prazosin | 2 | 2018 | 9 | 0.210 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2004 | 44 | 0.210 |
Why?
|
| United States | 10 | 2026 | 5205 | 0.200 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2009 | 116 | 0.200 |
Why?
|
| Drug Prescriptions | 1 | 2003 | 60 | 0.200 |
Why?
|
| Temazepam | 1 | 2002 | 1 | 0.200 |
Why?
|
| Breast Neoplasms | 2 | 2012 | 1723 | 0.190 |
Why?
|
| Saliva | 2 | 2014 | 119 | 0.190 |
Why?
|
| Accidents, Traffic | 1 | 2002 | 48 | 0.190 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 2 | 2015 | 65 | 0.190 |
Why?
|
| Azepines | 1 | 2022 | 22 | 0.180 |
Why?
|
| Primary Health Care | 4 | 2011 | 380 | 0.180 |
Why?
|
| Psychotherapy | 4 | 2018 | 59 | 0.180 |
Why?
|
| Case-Control Studies | 3 | 2016 | 1285 | 0.180 |
Why?
|
| Learning | 1 | 2021 | 161 | 0.160 |
Why?
|
| Dreams | 2 | 2018 | 10 | 0.160 |
Why?
|
| Aged | 10 | 2024 | 8214 | 0.150 |
Why?
|
| Prospective Studies | 3 | 2024 | 1600 | 0.150 |
Why?
|
| Anxiety | 3 | 2023 | 874 | 0.150 |
Why?
|
| Psychometrics | 3 | 2014 | 358 | 0.150 |
Why?
|
| Afghanistan | 1 | 2018 | 6 | 0.150 |
Why?
|
| Iraq | 1 | 2018 | 8 | 0.150 |
Why?
|
| Afghan Campaign 2001- | 1 | 2018 | 14 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2004 | 497 | 0.150 |
Why?
|
| Health Services Research | 2 | 2013 | 161 | 0.140 |
Why?
|
| Poverty | 1 | 2022 | 400 | 0.140 |
Why?
|
| Cognition | 1 | 2022 | 473 | 0.140 |
Why?
|
| Pilot Projects | 3 | 2012 | 760 | 0.140 |
Why?
|
| Drug Therapy, Combination | 4 | 2008 | 234 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2024 | 863 | 0.130 |
Why?
|
| Treatment Outcome | 6 | 2010 | 1604 | 0.130 |
Why?
|
| Implosive Therapy | 1 | 2016 | 14 | 0.130 |
Why?
|
| Medical Records | 2 | 2007 | 48 | 0.130 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 749 | 0.120 |
Why?
|
| Panic Disorder | 2 | 2008 | 102 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2017 | 165 | 0.120 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 65 | 0.120 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2013 | 120 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2017 | 167 | 0.120 |
Why?
|
| Prognosis | 2 | 2015 | 861 | 0.120 |
Why?
|
| Role | 1 | 2015 | 10 | 0.120 |
Why?
|
| Adaptation, Psychological | 2 | 2016 | 420 | 0.110 |
Why?
|
| Vietnam | 2 | 2006 | 62 | 0.110 |
Why?
|
| Violence | 1 | 2016 | 136 | 0.110 |
Why?
|
| Monitoring, Ambulatory | 1 | 2014 | 13 | 0.110 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 236 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2015 | 224 | 0.110 |
Why?
|
| Age Distribution | 1 | 2015 | 249 | 0.110 |
Why?
|
| Retrospective Studies | 3 | 2013 | 2544 | 0.110 |
Why?
|
| Down-Regulation | 1 | 2016 | 456 | 0.110 |
Why?
|
| Vitamin D | 1 | 2016 | 196 | 0.110 |
Why?
|
| Fourier Analysis | 1 | 2014 | 45 | 0.100 |
Why?
|
| Florida | 2 | 2007 | 478 | 0.100 |
Why?
|
| Models, Organizational | 1 | 2013 | 35 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2016 | 536 | 0.100 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 40 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 291 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2006 | 1067 | 0.100 |
Why?
|
| Length of Stay | 2 | 2012 | 229 | 0.100 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 284 | 0.100 |
Why?
|
| Electroencephalography | 1 | 2014 | 139 | 0.100 |
Why?
|
| Acute Disease | 2 | 2023 | 155 | 0.100 |
Why?
|
| Program Development | 1 | 2013 | 240 | 0.090 |
Why?
|
| Waist Circumference | 1 | 2013 | 90 | 0.090 |
Why?
|
| Colonic Polyps | 1 | 2013 | 71 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2013 | 2853 | 0.090 |
Why?
|
| Logistic Models | 1 | 2015 | 1009 | 0.090 |
Why?
|
| Adenoma | 1 | 2013 | 96 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2015 | 1759 | 0.090 |
Why?
|
| Child | 4 | 2014 | 3443 | 0.090 |
Why?
|
| Vulnerable Populations | 1 | 2013 | 166 | 0.090 |
Why?
|
| Chronic Disease | 2 | 2006 | 549 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1271 | 0.090 |
Why?
|
| Religion | 1 | 2012 | 90 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 154 | 0.090 |
Why?
|
| Life Style | 1 | 2013 | 334 | 0.080 |
Why?
|
| Piperazines | 2 | 2008 | 120 | 0.080 |
Why?
|
| Linear Models | 1 | 2011 | 317 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2012 | 210 | 0.080 |
Why?
|
| Wounds, Penetrating | 1 | 2010 | 22 | 0.080 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 238 | 0.080 |
Why?
|
| New Hampshire | 2 | 2007 | 5 | 0.080 |
Why?
|
| Cyclonic Storms | 1 | 2011 | 80 | 0.080 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 30 | 0.080 |
Why?
|
| Medically Uninsured | 1 | 2010 | 65 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2012 | 258 | 0.080 |
Why?
|
| Models, Biological | 1 | 2013 | 712 | 0.080 |
Why?
|
| Inflammation | 1 | 2015 | 758 | 0.080 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2009 | 3 | 0.080 |
Why?
|
| Dementia | 1 | 2011 | 160 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2010 | 110 | 0.080 |
Why?
|
| Generalization, Stimulus | 1 | 2009 | 1 | 0.070 |
Why?
|
| Health Status | 1 | 2013 | 442 | 0.070 |
Why?
|
| Convalescence | 1 | 2008 | 7 | 0.070 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2008 | 2 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2010 | 145 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2008 | 21 | 0.070 |
Why?
|
| Quinolones | 1 | 2008 | 14 | 0.070 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2008 | 15 | 0.070 |
Why?
|
| Aggression | 1 | 2008 | 102 | 0.070 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 2008 | 28 | 0.070 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2007 | 29 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 512 | 0.070 |
Why?
|
| Nipecotic Acids | 1 | 2007 | 2 | 0.070 |
Why?
|
| GABA Agonists | 1 | 2007 | 21 | 0.060 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2006 | 25 | 0.060 |
Why?
|
| Drug Therapy | 1 | 2006 | 17 | 0.060 |
Why?
|
| Domestic Violence | 1 | 2006 | 32 | 0.060 |
Why?
|
| Genotype | 1 | 2009 | 800 | 0.060 |
Why?
|
| Health Surveys | 1 | 2008 | 405 | 0.060 |
Why?
|
| Age Factors | 1 | 2009 | 1154 | 0.060 |
Why?
|
| Career Choice | 1 | 2026 | 52 | 0.060 |
Why?
|
| Gene Expression | 1 | 2009 | 701 | 0.060 |
Why?
|
| Sex Factors | 1 | 2009 | 1028 | 0.060 |
Why?
|
| Risk-Taking | 1 | 2008 | 457 | 0.060 |
Why?
|
| Registries | 1 | 2007 | 437 | 0.060 |
Why?
|
| Dissociative Disorders | 1 | 2005 | 19 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 734 | 0.060 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 65 | 0.060 |
Why?
|
| Emergency Medical Services | 1 | 2024 | 79 | 0.050 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2004 | 6 | 0.050 |
Why?
|
| Sertraline | 1 | 2004 | 7 | 0.050 |
Why?
|
| Community Mental Health Centers | 1 | 2003 | 2 | 0.050 |
Why?
|
| Mass Screening | 2 | 2024 | 541 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2005 | 233 | 0.050 |
Why?
|
| Incidence | 3 | 2013 | 1078 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 247 | 0.050 |
Why?
|
| Hypertension | 1 | 2009 | 835 | 0.050 |
Why?
|
| Schizophrenic Psychology | 1 | 2002 | 16 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 278 | 0.050 |
Why?
|
| Animals | 3 | 2015 | 16992 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2021 | 48 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 51 | 0.040 |
Why?
|
| Injury Severity Score | 2 | 2012 | 69 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2002 | 93 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1124 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 667 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2002 | 71 | 0.040 |
Why?
|
| Health Policy | 1 | 2002 | 184 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2024 | 392 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 611 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2008 | 830 | 0.040 |
Why?
|
| Depression | 1 | 2006 | 863 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2002 | 1063 | 0.040 |
Why?
|
| Hospitalization | 1 | 2002 | 485 | 0.040 |
Why?
|
| Hospitals, Veterans | 1 | 2018 | 15 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 440 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2018 | 60 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2014 | 1546 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 173 | 0.030 |
Why?
|
| Renin-Angiotensin System | 1 | 2015 | 48 | 0.030 |
Why?
|
| Women | 1 | 2012 | 28 | 0.020 |
Why?
|
| Database Management Systems | 1 | 2012 | 19 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2012 | 17 | 0.020 |
Why?
|
| New Orleans | 1 | 2011 | 17 | 0.020 |
Why?
|
| Research Support as Topic | 1 | 2012 | 89 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 2011 | 18 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2012 | 92 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 490 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 437 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 223 | 0.020 |
Why?
|
| Craniocerebral Trauma | 1 | 2010 | 22 | 0.020 |
Why?
|
| Mental Health Services | 1 | 2011 | 141 | 0.020 |
Why?
|
| Benztropine | 1 | 2008 | 1 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2008 | 30 | 0.020 |
Why?
|
| Psychology | 1 | 2008 | 39 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 341 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 638 | 0.020 |
Why?
|
| Demography | 1 | 2008 | 195 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 609 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 616 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2007 | 45 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 115 | 0.020 |
Why?
|
| Diet | 1 | 2013 | 826 | 0.020 |
Why?
|
| REM Sleep Parasomnias | 1 | 2006 | 1 | 0.020 |
Why?
|
| Infant | 1 | 2010 | 1175 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 2006 | 42 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2005 | 48 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 116 | 0.010 |
Why?
|
| Cause of Death | 1 | 2005 | 186 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2005 | 518 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 1081 | 0.010 |
Why?
|
| Critical Pathways | 1 | 2002 | 18 | 0.010 |
Why?
|
| Drug Utilization | 1 | 2002 | 34 | 0.010 |
Why?
|
| Forecasting | 1 | 2002 | 136 | 0.010 |
Why?
|
| Medicaid | 1 | 2002 | 143 | 0.010 |
Why?
|